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Abstract: Misdiagnosis of bipolar disorder is a serious, but not unusual problem for patients. 
Nevertheless, there are few biomarkers for distinguishing unipolar and bipolar disorder. 
Near-infrared spectroscopy (NIRS) is a noninvasive and useful method for the measurement of 
hemoglobin concentration changes in the cortical surface area, which enables the assessment of 
brain function. We measured NIRS and plasma monoamine metabolite levels in a patient with 
bipolar disorder. A 22-year-old man was admitted due to major depression. At admission, NIRS 
findings showed oxygenated hemoglobin reincrease in the posttask period, which is characteristic 
of schizophrenia. After treatment with paroxetine, he became manic with psychotic symptoms. 
His plasma level of homovanillic acid just before the manic switch was ten times higher than 
that just after paroxetine initiation. Treatment with lithium and antipsychotics was successful, 
and plasma homovanillic acid decreased after treatment. In this case, the NIRS findings may 
predict a possible risk of a manic switch, which is likely induced by paroxetine. NIRS may be 
able to help distinguish unipolar and bipolar disorder in clinical settings.
Keywords: near-infrared spectroscopy, bipolar disorder, homovanillic acid, diagnosis, 
biomarker
Introduction
Misdiagnosis of bipolar disorder is a potentially serious problem for patients, which 
sometimes leads to inappropriate treatment.1 However, it is not unusual for bipolar 
disorder to be misdiagnosed as a major depressive disorder.2 Previous studies have 
shown that the proportion of cases of bipolar disorder misdiagnosed as a major depres-
sive disorder is 20.8% –40%.2–4 Nevertheless, there are few biomarkers for accurate 
diagnosis. If patients become depressive for the first time and have never experienced 
a manic episode, it is difficult to determine whether that depressive episode is unipo-
lar or bipolar depression, and the risk of a manic switch is unknown. Near-infrared 
spectroscopy (NIRS) is a noninvasive and useful method that uses near-infrared light 
to measure hemoglobin concentration changes in the cortical surface area. Although 
changes in the NIRS signals measured on the forehead during the word fluency task 
may be partially associated with changes in skin blood flow,5 the changes in oxygen-
ated hemoglobin ([oxyHb]) are associated with changes in the regional cerebral blood 
volume. NIRS enables the assessment of brain function, and recent studies have shown 
that the frontal hemodynamic patterns detected by NIRS can be a biomarker for the 
diagnosis of major psychiatric disorders.6,7
In the present case, NIRS during the word fluency task was measured during the 
clinical course of bipolar disorder. In brief, [oxyHb] and deoxygenated hemoglobin 
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([deoxyHb]) were measured with a 52-channel NIRS 
machine (Hitachi ETG-4000; Hitachi Medical Corporation, 
Tokyo, Japan) at two wavelengths of near-infrared light 
(695 and 830 nm), the absorption of which was measured, 
and [oxyHb] and [deoxyHb] were calculated as previ-
ously described.8 The distance between pairs of source-
detector probes was set at 3.0 cm and each measured area 
between pairs of source detector probes was defined as a 
“channel”. The probes of the NIRS machine were fixed with 
3 × 11 thermoplastic shells, with the lowest probes located 
along the Fp1-Fp2 line according to the international 10–20 
system used in electroencephalography. We used the word 
fluency task because it is easy to understand and execute, and 
it is also an executive task that produces distinct differences 
in performance and neuroimaging data among each diag-
nostic group of psychiatric disorders.7 Additionally, plasma 
levels of homovanillic acid (HVA), a dopamine metabolite, 
and 3-methoxy-4hydroxyphenylglycol (MHPG), a nora-
drenaline metabolite, were measured longitudinally using 
high performance liquid chromatography. In our hospital, 
we measured both plasma levels of monoamine metabolites 
(every 3 weeks in principle) and NIRS (before and after the 
treatment) in psychiatric inpatients with mood disorders 
to investigate the association between plasma monoamine 
metabolites and NIRS signals. This protocol was approved 
by the ethics committee of Fukushima Medical University, 
and the patient consented to participate after having been 
informed of the purpose of the study.
Case report
The patient was a 22-year-old man who had no history of 
psychiatric illness. He was admitted to our hospital due 
to major depression that was diagnosed according to the 
 Diagnostic and Statistical Manual for Mental Disorders, 
Fourth Edition, with moderate sadness, agitation, retarda-
tion, and difficulty in concentrating. The clinical course 
after admission is summarized in Figure 1. We treated the 
patient with paroxetine and lorazepam for about 4 weeks, 
but treatment was not successful. On day 4, his Montgomery 
Åsberg Depression Rating Scale (MADRS) score was 44, and 
his plasma levels of HVA and MHPG were 4.6 ng/mL and 
1.9 ng/mL, respectively. Figure 2 shows the waveform 
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Figure 1 Clinical course after admission. 
Note: Figures next to each drug mean maximal dose. 
Abbreviations: BpD, biperiden; FNP, flunitrazepam; HVA, homovanillic acid; Li, lithium carbonate; LZP, lorazepam; MADRS, Montgomery Åsberg Depression Rating Scale; 
MHPG, 3-methoxy-4hydroxyphenylglycol; NIRS, near-infrared spectroscopy; OLZ, olanzapine; PAX, paroxetine; RIS, risperidone; YMRS, Young Mania Rating Scale; ZPC, 
zopiclone; ZTp, zotepine.
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of [oxyHb] during the cognitive activation of the word 
fluency task. NIRS signal changes were measured during a 
10 second pretask baseline period, a 60 second task period, 
and a 55 second posttask baseline period. The initial syllables 
assigned were changed every 20 seconds (/a/, /ka/, and /sa/, 
respectively) during the 60 second task period. During the 
task period, the patient was instructed to generate as many 
Japanese words beginning with the designated syllable as 
possible. In the pretask and the posttask baseline periods, 
the patient was instructed to repeat a train of syllables 
(/a/, /i/, /u/, /e/, and /o/). He sat on a chair in a room with 
daylight with his eyes open throughout the measurements. 
We focused on increases in [oxyHb], because this appears 
to reflect task-related cortical activation more directly than 
decreases in [deoxyHb].7 We defined the patterns of NIRS 
waveforms using the grand average waveforms in the frontal 
region (CH 25–28, CH 36–38, and CH 46–49; Figure 3) and 
two simple visual indices,7 integral value, and centroid value. 
The integral value describes the size of the hemodynamic 
response during the 60 second activation task period, whereas 
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Figure 3 regions of the near-infrared spectroscopy signals. 
Notes: The location of near-infrared spectroscopy measurements were anatomically labeled in the standard brain space. Reprinted from NeuroImage, Volume 85, Takizawa R, 
Fukuda M, Kawasaki s, et al; Joint project for psychiatric application of Near-Infrared spectroscopy (JpsY-NIrs) Group. Neuroimaging-aided differential diagnosis of the 
depressive state, pages 498–507, Copyright (2014), with permission from elsevier.7
Figure 2 Waveforms of oxygenated hemoglobin. 
Notes: (A) Waveforms of oxygenated hemoglobin during the cognitive activation of the word fluency task. (B) Grand average waveforms of oxygenated hemoglobin in the 
frontal region (CH 25, 26, 27, 28, 36, 37, 38, 46, 47, 48, and 49).
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the centroid value serves as an index of time course changes 
throughout the task, with periods representing the timing 
of the hemodynamic response.7 A recent study reported that 
the optimal threshold of the centroid value of the frontal 
region between major depressive disorder and two other 
disorders (schizophrenia and bipolar disorder) is 54 seconds 
(major depressive disorder , other 2 disorders).7 On day 4, 
the centroid value of the grand average in the central region 
was 68.6 seconds (Figure 2), and the NIRS waveforms 
showed an [oxyHb] reincrease in the posttask period 
(CH 34, 35, 36, 39, 45, 46, 47, and 49; Figure 2), which is 
characteristic of schizophrenia.6,7,9–11 On day 25, his MADRS 
score was 40, his plasma HVA level was markedly higher at 
49.3 ng/mL, and his plasma MHPG level was 1.6 ng/mL. 
On day 27, he was voluntarily discharged from the hospital, 
but was still in a depressive state. On day 30, 3 days after 
leaving the hospital, he became manic and was readmitted 
to our hospital. He was in a state of psychotic mania with 
elevated mood, grandiosity, aggression, auditory hallucina-
tion, and thought broadcast, with a Young Mania Rating 
Scale (YMRS) score of 48. Paroxetine and lorazepam were 
discontinued. We subsequently treated him with lithium, 
risperidone, and zotepine for approximately 3 weeks, and 
his manic state improved. On day 46, his YMRS score was 
29, and plasma levels of HVA and MHPG were 17 ng/mL 
and 1.3 ng/mL, respectively. However, he refused drugs 
because of extrapyramidal symptoms and became manic with 
psychotic symptoms again. Therefore, we tried a combina-
tion of lithium, olanzapine, and zotepine, and the treatment 
was successful. On day 77, the NIRS waveforms turned 
to a negative pattern (Figure 2), which was defined by an 
integral value of the grand average in the central region ,0, 
whereas there were [oxyHb] reincreases in the posttask 
period (CH 33, 41, 42, 43, 44, 51, and 52). On day 99, his 
YMRS score decreased to 3, and his plasma levels of HVA 
and MHPG were 8.7 ng/mL and 1.9 ng/mL, respectively. He 
was discharged from the hospital on day 106. Nine months 
later, he was off medication, became manic again, and was 
admitted to another psychiatric hospital.
Discussion
To the best of our knowledge, this is the first case report 
to measure both NIRS and plasma levels of monoamine 
metabolites in a patient with bipolar disorder, although the 
clinical course in this patient was not usual as the mania 
occurred within the first weeks of the initiation of serotonin 
selective reuptake inhibitor (SSRI) treatment. In this case, it 
was difficult to diagnose bipolar depression from only clini-
cal symptoms at his first admission. We could not predict the 
subsequent manic switch with psychotic features, which was 
likely caused by paroxetine. However, the results of NIRS on 
day 4 showed a pattern of schizophrenia, characterized by 
a smaller [oxyHb] increase during the first half of the task 
and an [oxyHb] reincrease in the posttask period,4,9–11 but 
not a unipolar depression pattern, which is characterized by 
only a smaller [oxyHb] increase during the first half of the 
period.4,9,12,13 Care must be taken to interpret these findings as 
patterns of diseases because of the small number of studies. 
An [oxyHb] reincrease in the posttask period is considered 
as inefficient activation of the prefrontal cortex,4,9,11 which 
is one of the quantitative abnormalities in schizophrenia.14 
These results may have predicted a possible risk of a manic 
switch in this patient. A recent study7 reported that the frontal 
hemodynamic patterns detected by NIRS accurately distin-
guished between patients with major depressive disorder and 
those with bipolar disorder or schizophrenia with depressive 
symptoms. This is consistent with the results in this patient. 
Although the clinical status of bipolar depression may be 
different from that of unipolar depression,1 it is not easy to 
clearly distinguish without a previous manic episode. In fact, 
most bipolar disorder patients with depressive symptoms are 
initially diagnosed as having major depression.2 Because 
there are few biomarkers for diagnosis, NIRS findings 
may help for distinguishing unipolar and bipolar disorders. 
However, NIRS signals changed after treatment with antipsy-
chotics and lithium in this patient. Although it is believed that 
NIRS waveforms are a possible trait marker, NIRS signals 
may change with the state or the medication.
Interestingly, NIRS findings in this case showed a pat-
tern of schizophrenia, not a pattern of bipolar disorder, 
which is characterized by a smaller [oxyHb] increase 
during the early period, and larger [oxyHb] increase dur-
ing the late period of this task.15 This result is consistent 
with a manic episode in this case that included psychotic 
symptoms such as hallucination and thought broadcast. 
Furthermore, 5 days before the manic switch, the patient’s 
plasma HVA level was almost ten times higher than just 
after admission. Because the HVA level change occurred 
in tandem with the manic symptoms during the clinical 
course, it is estimated that the manic episode in this case 
was associated with dopaminergic function. Plasma HVA 
levels have been considered as a possible indicator in the 
treatment of schizophrenia16,17 and bipolar disorder.18,19 
Furthermore, because SSRIs act on dopaminergic and sero-
tonergic neural systems,20 the increase in the plasma HVA 
level in this patient may have been induced by paroxetine. 
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A previous study reported that psychosis or mania induced 
by SSRIs showed a pattern of increased plasma HVA lev-
els.21 This is consistent with our findings of the changes 
in plasma HVA levels in this patient. Taken together, the 
NIRS findings in this patient may be based on dopaminergic 
dysfunction. However, the changes in the NIRS may not be 
directly associated with the changes in plasma HVA levels, 
because NIRS findings are based on frontal brain functions, 
whereas plasma HVA levels are related to psychotic symp-
toms,22 which seem to be a reflection of the mesolimbic 
dopamine system.
Conclusion
In this case, NIRS findings in a depressive state may predict 
the possible risk for a manic switch. NIRS may be able to 
help distinguish unipolar and bipolar disorders in clinical 
settings. Longitudinal monitoring of plasma HVA levels may 
be useful in the treatment of bipolar disorder, in particular 
in patients with psychotic symptoms like this case. These 
possible biomarkers may contribute to accurate diagnosis 
and appropriate treatment for bipolar disorder.
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